Mabion S.A. (WSE:MAB)
8.28
-0.03 (-0.36%)
Nov 3, 2025, 2:37 PM CET
Mabion Revenue
Mabion had revenue of 3.26M PLN in the quarter ending June 30, 2025, a decrease of -89.05%. This brings the company's revenue in the last twelve months to 11.24M, down -91.96% year-over-year. In the year 2024, Mabion had annual revenue of 69.02M, down -54.50%.
Revenue (ttm)
11.24M
Revenue Growth
-91.96%
P/S Ratio
11.95
Revenue / Employee
53.54K
Employees
213
Market Cap
134.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69.02M | -82.66M | -54.50% |
| Dec 31, 2023 | 151.68M | -12.30M | -7.50% |
| Dec 31, 2022 | 163.98M | 127.92M | 354.72% |
| Dec 31, 2021 | 36.06M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.04B |
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| Selvita | 373.90M |
| Celon Pharma | 206.22M |